Lafayette Investments, Inc. Enovis Corp Transaction History

Lafayette Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$43.67 - $57.07 $156,993 - $205,166	-3,595 Reduced 10.75%	29,832 $1.67 Million
Q3 2023 Oct 27, 2023	SELL	$51.65 - $65.54 $123,546 - $156,771	-2,392 Reduced 6.68%	33,427 $1.76 Million
Q2 2023 Jul 24, 2023	SELL	$52.7 - $64.12 $868,232 - $1.06 Million	-16,475 Reduced 31.5%	35,819 $2.3 Million
Q1 2023 Apr 20, 2023	SELL	$49.5 - $65.92 $36,283 - $48,319	-733 Reduced 1.38%	52,294 $2.8 Million
Q4 2022 Jan 24, 2023	SELL	$44.83 - $57.43 $717 - $918	-16 Reduced 0.03%	53,027 $0
Q3 2022 Oct 28, 2022	SELL	$46.07 - $60.1 $117,017 - $152,654	-2,540 Reduced 4.57%	53,043 $2.44 Million
Q2 2022 Jul 27, 2022	BUY	$55.0 - $70.47 $3.06 Million - $3.92 Million	55,583 New	55,583 $3.06 Million

314

60.6M

1.83M

661K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.31B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Lafayette Investments, Inc. with notifications on news.